Treatment Strategies for Myeloid Growth Factors and Intravenous Iron: When, What, and How?

Restricted access

Myeloid growth factors can reduce the risk of chemotherapy-induced neutropenia (CIN) and thus impact the survival of patients with cancer. Patients should be assessed for risk, taking into consideration patient-related risk factors and chemotherapy regimens. Patients stratified as having at least a 20% risk for CIN should be considered for prophylactic growth factors. The NCCN Guidelines for Myeloid Growth Factors provide category 1 recommendations for the daily use of filgrastim, tbo-filgrastim, and pegfilgrastim. Cancer-related anemia can be treated with erythropoiesis-stimulating agents, red blood cell transfusion, or intravenous iron.

Correspondence: Jeffrey Crawford, MD, Duke Cancer Institute, Duke University Medical Center, 441 Seeley G. Mudd Building, 10 Bryan Searle Drive, Box 3476, Durham, NC 27710. E-mail: crawf006@mc.duke.eduCorrespondence: George M. Rodgers, MD, PhD, Huntsman Cancer Institute at the University of Utah, Division of Hematology, University of Utah Medical Center, 30 North 1900 East, Rm 5C-402, Salt Lake City, UT 84132. E-mail:
  • 1.

    KudererNMDaleDCCrawfordJ. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer2006;106:22582266.

    • Search Google Scholar
    • Export Citation
  • 2.

    HirschBRLymanGH. Will biosimilars gain momentum?J Natl Compr Canc Netw2013;11:12911297.

  • 3.

    LymanGHKudererNMCrawfordJ. Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy. Cancer2011;117:19171927.

    • Search Google Scholar
    • Export Citation
  • 4.

    GilreathJAStenehjemDDRodgersGM. Diagnosis and treatment of cancer-related anemia. Am J Hematol2014;89:203212.

  • 5.

    GilreathJASajeserDSJorgensonJARodgersGM. Establishing an anemia clinic for optimal erythropoietic-stimulating agent use in hematology-oncology patients. J Natl Compr Canc Netw2008;6:577584.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 67 67 11
PDF Downloads 22 22 3
EPUB Downloads 0 0 0